Active substances
Acetylsalicylic acid + Oxycodone
- US FDA 4
- Health Canada 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| PERCODAN | 325MG;4.8355MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | ENDO OPERATIONS | Discontinued | 12 Apr 1950 |
| OXYCODONE AND ASPIRIN | 325MG;4.8355MG | tablet · oral | DR REDDYS LABS SA | Discontinued | 16 Mar 2011 |
| OXYCODONE AND ASPIRIN | 325MG;4.8355MG | tablet · oral | ACTAVIS LABS FL INC | Discontinued | 22 Mar 2011 |
| OXYCODONE AND ASPIRIN | 325MG;4.8355MG | tablet · oral | EPIC PHARMA LLC | Discontinued | 16 Jul 2020 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| TEVA-OXYCODAN | 00608157 | 5 MG; 325 MG | TABLET · ORAL | TEVA CANADA LIMITED |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.